Fig. 4

Cytokeratin 18 (CK18) immunostaining and patient prognosis. All bladder cancer patients had at least pT2 cancers and were treated by cystectomy
Cytokeratin 18 (CK18) immunostaining and patient prognosis. All bladder cancer patients had at least pT2 cancers and were treated by cystectomy